24 Apr 2017

BioGX Launches Four CE-marked IVD Assays at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

VIENNA, April 24, 2017 /PRNewswire/ -- BioGX, a Birmingham Alabama based molecular diagnostics company, announced the launch of four additional CE-IVD infectious disease tests at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), reflecting the inspiring vision of ECCMID: "Managing Infections, Promoting Science".

For the full Press Release click on link: http://finance.yahoo.com/news/biogx-launches-four-ce-marked-120800896.html